This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Aska Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Tomoaki Watanabe
Introduction
Tomoaki Watanabe is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyrimidine derivatives. His research focuses on developing compounds that can serve as effective treatments for various diseases.
Latest Patents
Watanabe holds a patent for a pyrimidine derivative, which is a compound represented by the formula (I) or a salt thereof. This compound exhibits mPGES-1 inhibitory activity, making it useful as an active ingredient in medications aimed at the prophylactic and therapeutic treatment of conditions such as inflammation, pain, and rheumatism. He has 1 patent to his name, showcasing his dedication to advancing medical science.
Career Highlights
Watanabe is currently employed at Aska Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to improving patient outcomes through the development of new therapeutic agents.
Collaborations
Throughout his career, Watanabe has collaborated with esteemed colleagues, including Makoto Okada and Youichi Nakano. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Tomoaki Watanabe's contributions to medicinal chemistry and his innovative work on pyrimidine derivatives highlight his importance in the field. His ongoing efforts at Aska Pharmaceutical Co., Ltd. continue to pave the way for advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile